Related references
Note: Only part of the references are listed.STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis
Wei-Hsin Lin et al.
ONCOGENE (2021)
Targeting FGFR inhibition in cholangiocarcinoma
Lipika Goyal et al.
CANCER TREATMENT REVIEWS (2021)
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma
Melanie A. Krook et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient
Banchob Sripa et al.
HUMAN CELL (2020)
Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways
Rattanaporn Jaidee et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells
Sirinapha Klungsaeng et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Down-regulation of STAT3 induces the apoptosis and G1 cell cycle arrest in esophageal carcinoma ECA109 cells
Chao Zhou et al.
CANCER CELL INTERNATIONAL (2018)
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
Se Hyun Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma
Lipika Goyal et al.
CANCER DISCOVERY (2017)
Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models
Rosaria Chila et al.
TRANSLATIONAL ONCOLOGY (2017)
Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand
Sunitta Saensa-ard et al.
TUMOR BIOLOGY (2017)
Cholangiocarcinoma
Michela Squadroni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
Selma Rivas-Fuentes et al.
JOURNAL OF CANCER (2015)
Essential role of AKT in tumor cells addicted to FGFR
Yi Hu et al.
ANTI-CANCER DRUGS (2014)
STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression
Hasaya Dokduang et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
Howard A. Burris
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Sumera Rizvi et al.
GASTROENTEROLOGY (2013)
Role of STAT3 in Cancer Metastasis and Translational Advances
Mohammad Zahid Kamran et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Fibroblast growth factors and their receptors in cancer
Jorgen Wesche et al.
BIOCHEMICAL JOURNAL (2011)
Signal Transducers and Activators of Transcription-3 Binding to the Fibroblast Growth Factor Receptor Is Activated by Receptor Amplification
Anna A. Dudka et al.
CANCER RESEARCH (2010)
The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma
Ke-jun Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma
Ke-Jun Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study
J. W. Valle et al.
BRITISH JOURNAL OF CANCER (2009)
Liver fluke induces cholangiocarcinoma
Banchob Sripa et al.
PLOS MEDICINE (2007)
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100)
Banchob Sripa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
K Vermeulen et al.
CELL PROLIFERATION (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Cancer control in Thailand
V Vatanasapt et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
